University of Cambridge
Institute of Therapeutic Immunology and Infectious Disease
This project will bring together a broad range of key industry partners to achieve three inter-related ambitions.
These are to:
- drive therapeutic breakthroughs in immune-related diseases
- explore new strategies for the control of globally important pathogens
- increase the likelihood of discovering important, high-value, new medicines in the UK by enhancing interactions between academia and the pharmaceutical industry.
The project will focus on autoimmune and inflammatory disease – for example Type 1 diabetes and inflammatory bowel disease – and the looming threat posed by antimicrobial resistance.